Mesoblast | MSB - Operating Profit

Stock Price
2.16
Daily Change
-0.01 -0.23%
Monthly
0.70%
Yearly
17.44%
Q2 Forecast
2.15

Mesoblast reported $-30.96M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Starpharma Holdings AUD -873K 1.43M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025